Compared with normal tissues, the expression of OFD1 aberrantly increased in multiple cancers, including colorectal cancer, glioblastoma, renal cancer, liver cancer, lung cancer, and prostate cancer (Supplementary Fig. 6c). Here, OFD1 is linked to prostate cancer.